This review summarises the evidence and examines the basis for develop
ing combined pill formulations since 1969. Some questions are raised a
bout sources of research funding and how these affect the direction in
which development occurs. The pill has proved a marked health gain fo
r women: misdirected refinement can reverse this trend.